Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-26-033637

President & CIO sold 664,826 shares at an average $36.34 ($24,160,402)

  • President & CIO acquired 664,826 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sukhatme Mayukh President & CIO 2026-08-14 Option exercise +243,177 $3.85 $936,231 18,873,916 D: show line 1 in the form
Sukhatme Mayukh President & CIO 2026-08-14 Sale −243,177 $36.23 $8,810,303 18,630,739 D: show line 2 in the form
Sukhatme Mayukh President & CIO 2026-08-17 Option exercise +284,707 $3.85 $1,096,122 18,915,446 D: show line 3 in the form
Sukhatme Mayukh President & CIO 2026-08-17 Sale −284,707 $36.25 $10,320,629 18,630,739 D: show line 4 in the form
Sukhatme Mayukh President & CIO 2026-08-18 Option exercise +105,141 $3.85 $404,793 18,735,880 D: show line 5 in the form
Sukhatme Mayukh President & CIO 2026-08-18 Sale −105,141 $36.59 $3,847,109 18,630,739 D: show line 6 in the form
Sukhatme Mayukh President & CIO 2026-08-18 Option exercise +31,801 $3.85 $122,434 18,662,540 D: show line 7 in the form
Sukhatme Mayukh President & CIO 2026-08-18 Sale −31,801 $37.18 $1,182,361 18,630,739 D: show line 8 in the form
Open-market sales · 664,826 sh · avg $36.34 · $24,160,402

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sukhatme Mayukh President & CIO 2026-08-14 Option exercise · Common Shares −243,177 13,981,186 D: show line 9 in the form
Sukhatme Mayukh President & CIO 2026-08-17 Option exercise · Common Shares −284,707 13,696,479 D: show line 10 in the form
Sukhatme Mayukh President & CIO 2026-08-18 Option exercise · Common Shares −136,942 13,559,537 D: show line 11 in the form
Loading xslF345X06/form4.xml…